当前位置: X-MOL 学术Eur. J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening
European Journal of Medicinal Chemistry ( IF 6.0 ) Pub Date : 2016-10-11 , DOI: 10.1016/j.ejmech.2016.10.019
Guang-Hui Ma , Yan Ye , Dan Zhang , Xin Xu , Pei Si , Jian-Long Peng , Yong-Long Xiao , Rui-Yuan Cao , Yu-Ling Yin , Jing Chen , Lin-Xiang Zhao , Yu Zhou , Wu Zhong , Hong Liu , Xiao-Min Luo , Li-Li Chen , Xu Shen

Hand, foot and mouth disease (HFMD) is a serious, highly contagious disease. HFMD caused by Enterovirus 71 (EV71), results in severe complications and even death. The pivotal role of EV71 3Cpro in the viral life cycle makes it an attractive target for drug discovery and development to treat HFMD. In this study, we identified novel EV71 3Cpro inhibitors by docking-based virtual screening. Totally 50 compounds were selected to test their inhibitory activity against EV71 3Cpro. The best inhibitor DC07090 exhibited the inhibition potency with an IC50 value of 21.72 ± 0.95 μM without apparent toxicity (CC50 > 200 μM). To explore structure-activity relationship of DC07090, 15 new derivatives were designed, synthesized and evaluated in vitro enzyme assay accordingly. Interestingly, four compounds showed inhibitory activities against EV71 3Cpro and only DC07090 inhibited EV71 replication with an EC50 value of 22.09 ± 1.07 μM. Enzyme inhibition kinetic experiments showed that the compound was a reversible and competitive inhibitor. The Ki value was determined to be 23.29 ± 12.08 μM. Further molecular docking, MD simulation and mutagenesis studies confirmed the binding mode of DC07090 and EV71 3Cpro. Besides, DC07090 could also inhibit coxsackievirus A16 (CVA16) replication with an EC50 value of 27.76 ± 0.88 μM. Therefore, DC07090 represents a new non-peptidyl small molecule inhibitor for further development of antiviral therapy against EV71 or other picornaviruses.



中文翻译:

通过基于结构的虚拟筛选鉴定DC07090作为新型抗人肠病毒71 3C蛋白酶的强效小分子抑制剂并进行生化鉴定

手足口病(HFMD)是一种严重的,高度传染性的疾病。肠道病毒71(EV71)引起的手足口病会导致严重的并发症甚至死亡。EV71 3C pro在病毒生命周期中的关键作用使其成为治疗HFMD的药物发现和开发的有吸引力的目标。在这项研究中,我们通过基于对接的虚拟筛选确定了新型EV71 3C pro抑制剂。总共选择了50种化合物来测试它们对EV71 3C pro的抑制作用。最好的抑制剂DC07090表现出抑制作用,IC 50值为21.72± 0.95μM,无明显毒性(CC 50 > 200μM)。为了探索DC07090的构效关系,设计了15种新的衍生物,进行了合成和体外酶评价。有趣的是,四种化合物显示出对EV71 3C pro的抑制活性,只有DC07090抑制了EV71复制,EC 50值为22.09± 1.07μM 。酶抑制动力学实验表明该化合物是可逆的竞争性抑制剂。Ki值确定为23.29±12.08μM。进一步的分子对接,MD模拟和诱变研究证实了DC07090和EV71 3C pro的结合模式。此外,DC07090还可以通过EC 50抑制柯萨奇病毒A16(CVA16)复制值为27.76±0.88μM。因此,DC07090代表了一种新的非肽基小分子抑制剂,可用于进一步开发针对EV71或其他小核糖核酸病毒的抗病毒治疗。

更新日期:2016-10-11
down
wechat
bug